A company focused on supporting the progress of promising innovations in healthcare through investing.

Perceptive Advisors

SSL by Default

Google Maps

DMARC

DNSSEC

Microsoft

Squarespace Hosted

403 Error

Squarespace

Mimecast

Chief Compliance Officer

Alexander Rakitin

COO-

James Mannix

Joe Edelman

Board Member

Todd Wider

Vice President

Harry Jenq

Managing Director

Craig Yeshion

Business Management

Doug Giordano

Hossein Ekrami

Marketing and Product

Konstantin Poukalov

Assistant Controller

Nicole Booth, CPA

Ellen Hukkelhoven

Joseph Edelman

CEO & Founder

Adam Stone

Chief Investment Officer

Sam Chawla

Manager

Chris Garabedian

Portfolio Manager

Orly Mishan

Managing Director, Perceptive Discovery

Takeru Furuya

Principal, Venture (PXV Funds)

Keyvan Mirsaeedi-Farahani

enGene is a biotechnology company develops treatment for mucosal diseases through inducing therapeutic proteins of harmful proteins.

Clover is a healthcare technology company helping members live their healthiest lives with its Medicare Advantage plans.

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.

Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

Outset Medical is a medical technology company that offers reimagining dialysis for patients and providers.

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Venture Stage Investors Hedge Funds

Early Stage Venture Investors with Investments in Pennsylvania

Venture Stage Investors with Investments in Switzerland

Venture Stage Investors with Investments in Vancouver, British Columbia

Perceptive Advisors is a privately owned hedge fund sponsor. The firm invests in the public equity markets across the globe. It employs a long/short equity strategy as a hedging technique while investing. The firm typically invests in the biotechnology and life sciences sectors to make its investments. Perceptive Advisors is based in New York, New York.

Perceptive Xontogeny Venture Fund II

Perceptive Credit Opportunities Fund III

Perceptive Xontogeny Venture Fund

Perceptive Credit Opportunities Fund

New York

United States

North America

Orpyx Secures $20M Investment Led by Perceptive Advisors

The 10 Biggest Rounds Of June: Cruise And AlphaSense Nab Top Spots For Month

United Kingdom

Europe

India

Asia

Austria

Bangladesh

ARYA Sciences Acquisition Corp IV does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

ARYA Sciences Acquisition Corp IV

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 18, 2024 4:35 AM	8c81337f
news daily refresh	general	Aug 21, 2024 7:50 AM	ef7c0562
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 18, 2024 7:04 AM	c13f59af
company summary	general
signals	general
crunchbase trigger	general	Oct 28, 2024 1:50 PM	08bb8917
crunchbase profile	general	Oct 28, 2024 2:46 PM	3ab76092
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	5f0b0657
peers	general	Jul 18, 2024 4:35 AM	04e32945
news basic	general	Jul 18, 2024 4:35 AM	a33032b0
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:PERCEPTIVELIFE

Perceptive Advisors

Last Close

9.10

31/07 20:00

Market Cap

86.82M

Beta: -

Volume Today

90.41K

Avg: -